Juliana Beal, Medical oncologist at Hospital Israelita Albert Einstein, shared on X:

“So I just got one of the most special notifications of my career: our ETAC-S paper was published in Annals of Oncology. It was an amazing group effort by an extraordinary group of people lead by Vivek Subbiah, George Pentheroudakis, Ben Westphalen.

With the contribution of so many brilliant oncologists our group tried to establish a list of ‘minimum requirements’ for a drug within a trial to be graduated as having tumor-agnostic potential.

It’s worth the read!”

‘The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development‘

Autors: C.B. Westphalen , D. Martins Branco, J.R. Beal, C. Cardone, N. Coleman, A.M. Schram, S. Halabi, S. Michiels, C. Yap, F. André, F. Bibeau, G. Curigliano, E. Garralda, S. Kummar, R. Kurzrock, S. Limaye, S. Loges, A. Marabelle, C. Marchió, J. Mateo, J. Rodon, T. Spanic, G. Pentheroudakis, V. Subbiah

Juliana Beal: Our ETAC-S paper was published in Annals of Oncology

Source: Juliana Beal/X